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Summary
 
Migration of antigen-activated CD4 T cells to B cell areas of lymphoid tissues is important for
mounting T cell–dependent antibody responses. Here we show that CXC chemokine receptor
(CXCR)5, the receptor for B lymphocyte chemoattractant (BLC), is upregulated on antigen-spe-
cific CD4 T cells in vivo when animals are immunized under conditions that promote T cell mi-
gration to follicles. In situ hybridization of secondary follicles for BLC showed high expression in
mantle zones and low expression in germinal centers. When tested directly ex vivo, CXCR5
 
hi
 
 T
cells exhibited a vigorous chemotactic response to BLC. At the same time, the CXCR5
 
hi
 
 cells
showed reduced responsiveness to the T zone chemokines, Epstein-Barr virus–induced molecule 1
(EBI-1) ligand chemokine (ELC) and secondary lymphoid tissue chemokine (SLC). After adop-
tive transfer, CXCR5
 
hi
 
 CD4 T cells did not migrate to follicles, indicating that additional changes
may occur after immunization that help direct T cells to follicles. To further explore whether T
cells could acquire an intrinsic ability to migrate to follicles, CD4
 
2
 
CD8
 
2
 
 double negative (DN) T
cells from MRL-lpr mice were studied. These T cells normally accumulate within follicles of
MRL-lpr mice. Upon transfer to wild-type recipients, DN T cells migrated to follicle proximal
regions in all secondary lymphoid tissues. Taken together, our findings indicate that reprogram-
ming of responsiveness to constitutively expressed lymphoid tissue chemokines plays an impor-
tant role in T cell migration to the B cell compartment of lymphoid tissues.
Key words: chemokine • CXCR5 • ELC • follicle • T lymphocyte
T
 
cell–dependent antibody responses require cognate in-
teraction between antigen-presenting B cells and anti-
gen-specific T cells (1, 2). Antigen-mediated cross-linking
of the B cell receptor promotes B cell localization at the
boundary between T zone and follicles (for a review, see
reference 3), the location of the earliest encounters between
antigen-bearing B cells and antigen-specific T cells (4–6).
After receiving signals from activated CD4 T cells, some B
cells undergo differentiation into plasmablasts, which migrate
to the red pulp of spleen or medullary cords of LNs and be-
come antibody-secreting plasma cells. Other activated B cells
move into the follicle and form a germinal center (GC)
 
1
 
(1). The GC is strongly dependent on help from antigen-
specific T cells that must migrate into the follicle to support
this response (7–12). Movement of antigen-specific T cells
has been studied within lymphoid tissues using an adoptive
T cell transfer model (13). When recipients of OVA-specific
TCR-transgenic CD4
 
1
 
 T cells are immunized with OVA
in adjuvant, there is a short period of transgenic T cell pro-
liferation in the T zone, and then large numbers of these
cells are induced to migrate into follicles (13). T cell migra-
tion to follicles has also been studied in nontransgenic mice
during the response to pigeon cytochrome c (PCC [7, 9,
14]). The predominant responding T cell population ex-
presses TCR containing V
 
a
 
11 and V
 
b
 
3 (15, 16). When
mice are immunized with PCC in adjuvant, a protocol that
induces a strong GC response, V
 
a
 
11V
 
b
 
3-expressing T cells
are found to begin localizing in follicles by day 5 and to
peak in number at day 10, with many of the cells at this
time being resident in GCs (7, 9, 10, 14, 17). In contrast to
these findings, when mice are given antigen in saline intra-
venously, T cells become activated but fail to migrate into
follicles. Many of the cells are quickly eliminated, and those
 
1
 
Abbreviations used in this paper:
 
 B6, C57BL/6; BLC, B lymphocyte
chemoattractant; BLR, Burkitt’s lymphoma receptor; CFSE, 5- (and 6-)
carboxyfluorescein succinimidyl ester; CXCR, CXC chemokine recep-
tor; DC, dendritic cell; DN, double negative; EBI-1, EBV-induced mol-
ecule 1; ELC, EBI-1 ligand chemokine; GC, germinal center; MIP, mac-
rophage inflammatory protein; PCC, pigeon cytochrome c; SDF, stromal
cell–derived factor; SLC, secondary lymphoid tissue chemokine.
 1124
 
Chemokine Responsiveness of Follicle-homing T Cells
 
that remain respond poorly to subsequent antigen exposure
(13). Therefore, CD4 T cell migration into follicles has
been suggested to be important for supporting not only B
cell responses, but also a fully developed T cell response
and induction of T cell memory.
The understanding of how antigen-specific T cells migrate
to follicles is poorly developed. Recently, several chemo-
kines have been characterized that are constitutively ex-
pressed in lymphoid tissues and help direct the movements
of resting and activated lymphocytes. B lymphocyte chemo-
attractant (BLC [18]; also called B cell–attracting chemo-
kine 1 [BCA-1; 19]) is a CXC chemokine made by stromal
cells in lymphoid follicles that functions as a ligand for CXC
chemokine receptor 5 (CXCR5, previously called Burkitt’s
lymphoma receptor [BLR1]) (20). Gene knockout studies
have established that CXCR5 is required for B cell homing
to follicles in spleen and Peyer’s patches (21). In vitro, BLC
was shown to be an efficacious attractant of B cells while
attracting few T cells and no myeloid cells (18, 19). Two
CC chemokines, secondary lymphoid tissue chemokine (SLC,
also called 6-Ckine) and EBV-induced molecule 1 (EBI-1)
ligand chemokine (ELC, also called macrophage inflamma-
tory protein [MIP]-3
 
b
 
), are constitutively expressed by cells
in the T zone (22, 23). SLC and ELC are ligands for CC
chemokine receptor 7 and both strongly attract resting and
in vitro–activated T cells (22–30). Mice that lack SLC ex-
pression (and have reduced ELC expression) have defective
homing of T cells into LNs and splenic T cell areas (31).
Previous studies have shown that while most T cells are
negative for CXCR5, a subset of memory phenotype cells
are CXCR5
 
1
 
 (20, 21). Here we have investigated the rela-
tionship between acquisition of CXCR5 expression by
CD4 T cells and homing to lymphoid follicles. We estab-
lish that CXCR5 upregulation and acquisition of BLC re-
sponsiveness of in vivo–activated CD4 T cells occur with a
time course consistent with a role in directing T cells to
follicles. We also establish that at the same time as upregu-
lating CXCR5, in vivo–activated CD4 T cells downregu-
late their response to ELC and SLC. Finally, we demon-
strate that CD4
 
2
 
CD8
 
2
 
 double negative (DN) T cells from
MRL-lpr mice express CXCR5 and, upon transfer to nor-
mal recipients, migrate to follicle proximal locations in all
secondary lymphoid tissues, establishing that T cells can ac-
quire the intrinsic ability to migrate to B cell follicles.
 
Materials and Methods
 
Mice.
 
Six 10-wk-old Balb/cAnN mice were obtained from
Charles River Laboratories. C57BL/6 (B6), MRL/MpJ (MRL),
and MRL/Mp-
 
lpr/lpr
 
 (MRL-lpr) mice were from The Jackson
Laboratory. DO11.10 TCR-transgenic mice (32) on the Balb/c
background, and aged and control B6 mice for memory T cell
analysis were maintained in the University of California at San
Francisco animal care facility. Eight 10-wk-old, specific patho-
gen-free, male B10.BR mice (The Jackson Laboratory) were
housed under barrier conditions at the Duke University Vivarium.
 
Chemokines.
 
HIS
 
6
 
-tagged murine BLC was prepared by
PCR-based insertion of six histidine codons preceding the BLC
stop codon. The BLC-his6 construct was inserted into the CMV-
based mammalian expression vector pRK5 (33) and stably trans-
fected into HEK-293 cells using the Lipotaxi Mammalian Transfec-
tion kit (Stratagene) according to the manufacturer’s instructions.
HIS
 
6
 
-BLC was purified from tissue culture supernatants using an
NiNTA column (Qiagen). The protein was eluted in 100 
 
m
 
M
imidazole (Fisher Scientific Co.). SDS-PAGE separation of the
eluate revealed a band representing 
 
.
 
90% of total protein corre-
sponding to the recombinant HIS
 
6
 
-BLC. HIS
 
6
 
-ELC was produced
in bacteria and purified as described (23). A similarly constructed
vector for bacterial HIS
 
6
 
-SLC production was a gift from M. Gunn
(Duke University, Durham, NC). Stromal cell–derived factor
(SDF)1
 
a
 
 (N33A) produced by chemical ligation (Gryphon Sci-
ences), HIS
 
6
 
-BLC, -ELC, and -SLC were used in all chemotaxis
assays, except for MRL-lpr chemotaxis where, due to availability
at the time of the experiments, non–HIS-tagged murine SLC (gift
of M. Gunn) and human ELC (R&D Systems) were used. We
have not observed significant differences in the response of mouse
cells to mouse or human ELC.
 
DO11.10 T Cell Adoptive Transfer, OVA Immunization, and
Recipient Analysis.
 
Adoptive transfer and immunization of recip-
ients were carried out essentially as described (13). Lymphocytes
were isolated from LNs or spleen of DO11.10 donor mice, and
the percentage of OVA
 
323–339
 
 peptide/I-A
 
d
 
–specific CD4
 
1
 
 T cells
was determined by flow cytometric analysis of an aliquot of cells
stained with FITC-conjugated clonotypic mAb KJ1-26 and anti-
CD4–PE (Caltag). 2.5 
 
3
 
 10
 
6
 
 KJ1-26
 
1
 
CD4
 
1
 
 cells were adop-
tively transferred into sex-matched Balb/c recipients by intrave-
nous injection. The day after cell transfer, mice were immunized
with 300 
 
m
 
g OVA
 
323–339
 
 peptide either emulsified in CFA (Sigma
Chemical Co.) and injected subcutaneously in a total volume of
0.1 ml distributed over three points on the back, or in sterile PBS
by intravenous injection. Recipients were killed and dissected 2,
3, 5, 7, 10, 14, or 25 d after immunization. In a second immuni-
zation protocol (34), mice were injected subcutaneously with 2 mg
OVA protein (Sigma Chemical Co.) mixed in 0.2 ml of 250 
 
m
 
g/ml
LPS (Sigma Chemical Co.). For subcutaneously injected mice,
lymphocytes were isolated from axillary and brachial LNs. For in-
travenously injected mice, cells from mandibular, cervical, axil-
lary, brachial, inguinal, and in some cases mesenteric nodes were
pooled. The remaining peripheral LNs were frozen in OCT (Miles,
Inc.) for sectioning. Flow cytometric analysis was performed us-
ing affinity-purified anti-CXCR5 rabbit antiserum (35), followed
by biotinylated goat anti–rabbit IgG (PharMingen) with normal
mouse and rat serum (1:100 dilution), and then streptavidin-
Cychrome (PharMingen), KJ1-26–FITC, anti-B220–PE, and
anti-CD8–PE (Caltag).
 
PCC Immunization and Flow Cytometry.
 
Whole PCC (Sigma
Chemical Co.) was diluted into PBS and mixed with the Ribi
adjuvant system (RAS; Ribi Immunochem Research). B10.BR
mice were immunized with 400 
 
m
 
g of PCC in 200 
 
m
 
l of adju-
vant emulsion in two 100-
 
m
 
l doses by subcutaneous injection on
either side of the base of the tail. Animals were killed at 3, 5, 7,
and 9 d after immunization, and the draining LNs were harvested
as described previously (17). In brief, inguinal and periaortic
nodes were collected, and using 0.17 M NH
 
4
 
Cl solution for
erythrocyte lysis were made into single cell suspensions. Cells
were incubated with anti-CXCR5 rabbit antiserum, followed by
anti–rabbit IgG-biotin (Santa Cruz Biotechnology). After block-
ing with normal rabbit and mouse serum (1:100 dilution) for 5 min,
staining was completed using streptavidin-PE (PharMingen),
anti-V
 
a
 
11–FITC (PharMingen), anti-V
 
b
 
3–allophycocyanin, anti-
B220–Cy5PE (PharMingen), anti-CD8–Cy5PE (PharMingen),
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anti-CD11b–Cy5PE (Caltag), and anti-CD44–Texas red. Finally,
cells were resuspended in 2 
 
m
 
g/ml propidium iodide (for dead
cell exclusion) in PBS with 5% FCS. The cells were analyzed us-
ing a dual laser modified FACStar
 
PLUS™
 
 (Becton Dickinson Immu-
nocytometry Systems; an argon laser as the primary, a tunable dye
laser as the secondary) capable of seven-parameter collection.
Files were acquired using CELLQuest™ software (Becton Dick-
inson) and analyzed using FlowJo software (Tree Star, Inc.).
 
Chemotaxis Assays.
 
Chemotaxis assays were performed as
described (23) using 10
 
6
 
 total cells per 5-
 
m
 
m transwell (Corning
Costar Corp.). To identify migrating populations, a fraction of
transmigrated cells was stained and analyzed by flow cytometry.
Transmigrated LN cells from Balb/c recipients of OVA-specific
T cells were stained with KJ1-26–FITC and anti-CD4–TriColor
(Caltag), or with anti-CD4–PE (Caltag) and KJ1-26–biotin fol-
lowed by streptavidin-Cychrome (PharMingen). Because BLC
causes reversible internalization of CXCR5 (36), transmigrated
splenocytes from aged B6 mice were washed twice and incubated in
RPMI plus
 
 
 
0.5% BSA for 1 h at 37
 
8
 
C, 5% CO
 
2
 
 to allow CXCR5
reexpression before staining with anti-CXCR5 rabbit antiserum/
goat anti–rabbit IgG-biotin/streptavidin-Cychrome, anti-CD4–
FITC (Caltag), and anti-CD62L–PE (PharMingen). LN suspen-
sions from 5–8-mo-old MRL-lpr mice were stained with anti-
B220–PE, anti-Thy1.2–biotin (Caltag), and anti-CXCR5 rabbit
antiserum followed by goat anti–rabbit IgG-FITC (Caltag) and
streptavidin-Cychrome. To provide an internal control, MRL-lpr
splenocytes (70% Thy1
 
1
 
B220
 
1
 
, 9% Thy1
 
1
 
B220
 
2
 
) were mixed
3:1 with B6 splenocytes (
 
,
 
1% Thy1
 
1
 
B220
 
1
 
, 27% Thy1
 
1
 
B220
 
2
 
)
for chemotaxis assays. Transmigrated cells were stained with anti-
Thy1.2–FITC (Caltag), anti-B220–PE, and anti-CD21–biotin/
streptavidin-Cychrome.
 
MRL-lpr DN T Cell and Aged B6 CXCR5
 
hi
 
 T Cell Adoptive
Transfers.
 
DN T cells were purified from LNs of 5–8-mo-old
MRL-lpr mice. Total LN cells were incubated with biotinylated
mAbs against CD22 (PharMingen), CD4, and CD8 (Caltag) fol-
lowed by streptavidin-coated magnetic beads, and then passed
over a MACS
 
® 
 
column (Miltenyi Biotec). Memory phenotype
splenocytes from 14-mo-old mice were enriched by MACS
 
®
 
 de-
pletion with biotinylated mAbs against CD8, B220, and CD11b
(Caltag). For all transfers, 2 
 
3
 
 10
 
7
 
 cells were labeled with 5- (and
6-)carboxyfluorescein succinimidyl ester (CFSE; Molecular
Probes) as described (35) and transferred by intravenous injection
into appropriate syngeneic (MRL or B6) recipients. After 
 
z
 
24 h,
recipients were killed, and spleen, LNs, and Peyer’s patches were
frozen in OCT for sectioning.
 
Immunohistochemistry, Immunofluorescence Microscopy, and In Situ Hy-
bridization.
 
For immunohistochemistry, cryostat sections (7–8 
 
m
 
m)
were fixed and stained as described previously (35) with the fol-
lowing reagents: biotinylated or FITC-conjugated KJ1-26, rat
anti-CD4 and anti-CD8 (Caltag), and biotinylated peanut agglu-
tinin (PNA; Sigma Chemical Co.). Biotinylated reagents were
detected with avidin–alkaline phosphatase (Sigma Chemical Co.),
rat mAbs with horseradish peroxidase–conjugated goat anti–rat
IgG (Southern Biotechnology Associates), and KJ1-26–FITC with
horseradish peroxidase–conjugated antifluorescein (NEN). Enzyme
reactions were developed with conventional substrates for perox-
idases (diaminobenzidine/H
 
2
 
O
 
2
 
; Sigma Chemical Co.) and alka-
line phosphatase (Fast Red/Naphthol AS-MX; Sigma Chemical
Co.). Endogenous alkaline phosphatase activity was blocked with
levamisole (Sigma Chemical Co.). Some sections were counter-
stained with hematoxylin (Fisher Scientific Co.). Sections were
mounted in crystal mount (Biomeda Corp.). For immunofluores-
cence microscopy, unfixed sections were air-dried and incubated
with biotinylated mAbs against CD8, CD4, or Thy1.2 (Caltag)
and CD3
 
e
 
 (PharMingen) followed by streptavidin-Cy3 (Jackson
ImmunoResearch Labs). Three-color staining of spleen sections
was achieved by costaining with rat anti–MOMA-1 (37) followed
by goat anti–rat IgG-aminomethylcoumarin (Jackson Immuno-
Research Labs). Sections were mounted in Fluoromount G
(Southern Biotechnology Associates), viewed, and photographed
as described (35). In situ hybridization analysis was performed as
described (23) using a BLC probe spanning nucleotides 27–1042
of mouse BLC (18).
 
Results
 
Immunization Conditions that Promote Antigen-specific CD4 T
Cell Homing to Follicles Cause Rapid Upregulation of CXCR5
Expression.
 
Mice that had received an inoculum of OVA-
specific TCR-transgenic (DO11.10) T cells were injected
with OVA
 
323–339
 
 peptide either subcutaneously in CFA to
promote T cell trafficking to follicles, or intravenously in
PBS to promote transient T cell activation without migra-
tion to follicles (13). At days 2, 3, 5, and 10 after immuni-
zation, LNs were isolated and analyzed by flow cytometry
with a clonotypic antibody, KJ1-26, that recognizes the
transferred OVA-specific T cells, and with an antiserum
specific for CXCR5 (35, 36). Before immunization, trans-
ferred OVA-specific T cells were uniformly CXCR5
 
lo/
 
2
 
(Fig. 1 A). However, within 2 d of immunization with
peptide in CFA, when OVA-specific T cell numbers in the
draining LNs start to increase (13), a subpopulation of
CXCR5
 
1
 
 cells could be identified (Fig. 1 B). By day 3,
when the OVA-specific T cell frequency had increased
 
z
 
30-fold, as in previous studies (13), most of the antigen-
specific cells expressed high levels of CXCR5 (fluorescence
intensity at least 10-fold greater than the staining control),
and after 5 d the cells were uniformly CXCR5
 
hi
 
 (Fig. 1, C
and D). Appearance of T cells in follicles followed similar
kinetics to the CXCR5 upregulation (Fig. 2). Consistent
with previous reports (13, 34), KJ1-26
 
1
 
 OVA-specific T
cells began appearing in follicles by day 3 after immuniza-
tion (Fig. 2 A) and reached maximal numbers by day 5
(Fig. 2 B). An enlargement of draining LN B cell areas oc-
curred over this time period, and by day 5 many of the fol-
licles contained nascent GCs (Fig. 2 B). Immunization of
mice with OVA protein in LPS, a protocol that has been
shown to promote T cell trafficking to follicles (34), also
led to increased expression of CXCR5 on CD4 T cells
(Fig. 1 F). In contrast to these effects, intravenous injection
of OVA peptide in saline led to only weak induction of
CXCR5 on OVA-specific T cells in LNs (Fig. 1, A–E) and
spleen (data not shown), and did not promote KJ1-26
 
1
 
 T
cell migration into follicles (Fig. 2 C). When mice immu-
nized with OVA peptide in CFA were followed for longer
times, a decline in CXCR5 expression was found to occur,
although a significant proportion of KJ1-26
 
1
 
 cells remained
CXCR5
 
hi
 
 at day 10 after immunization (Fig. 1 E), and
CXCR5
 
hi
 
 cells could still be detected at day 25 (data not
shown). By day 10, many B cell areas had become second-
ary follicles, comprising a well-developed GC and a sur-
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rounding mantle of small resting B cells (Fig. 2 D). Signifi-
cant numbers of KJ1-26
 
1
 
 T cells were detectable in the
secondary follicles, with many residing in the mantle zone
and smaller numbers being associated with the outer zone
of GCs (Fig. 2 D). BLC in situ hybridization analysis of
LNs containing well-developed GCs showed that BLC was
highly expressed in the follicular mantle zones (Fig. 2, E
and F). Within GCs, only occasional cells could be identi-
fied that hybridized with the BLC probe, and these cells
tended to be most frequent in the area of the GC distal to
the T zone (Fig. 2, E and F). This is also the region of the
GC most enriched for CD4 T cells (1; Fig. 2 D).
 
CXCR5 Upregulation on V
 
a
 
11V
 
b
 
3-expressing Cells during
the PCC Response.
 
To test whether CXCR5 was upregu-
lated on nontransgenic T cells under conditions not involving
T cell transfer, the phenotype of PCC-specific V
 
a
 
11V
 
b
 
3-
expressing CD4 T cells was followed in mice immunized
subcutaneously with PCC protein in adjuvant. V
 
a
 
11V
 
b
 
3-
expressing T cells responding to PCC were detected in im-
munized, but not unimmunized, animals by upregulation
of CD44 (Fig. 3 A). CXCR5 expression became detectable
on a subset of PCC-responsive V
 
a
 
11
 
1
 
V
 
b
 
3
 
1
 
 T cells by day 3
after immunization (Fig. 3 A). This subpopulation grew in
frequency through day 9 (Fig. 3 B), reaching maximal total
numbers by day 7 (Fig. 3 C). These kinetics of CXCR5 ex-
pression are in close accord with the kinetics of V
 
a
 
11V
 
b
 
3-
expressing T cell accumulation in follicular mantle zones
and GCs during the response to PCC (9, 17). A subpopula-
tion of the responding CD44
 
1
 
 V
 
a
 
11V
 
b
 
3-expressing T cells
did not upregulate CXCR5 (Fig. 3). Such bimodality was
not observed in the response of the monoclonal DO11.10
T cells to OVA peptide (Fig. 1 D) and may indicate that T
cells with differing affinity for peptide/MHC differ in their
propensity to upregulate CXCR5.
 
Increased Responsiveness of CXCR5-expressing T Cells to
the Follicular Chemokine BLC.
 
The rapid upregulation of
CXCR5 on T cells after injection of antigen in adjuvant
and the migration of a fraction of the cells into follicles
suggested that these cells had acquired responsiveness to
BLC. This was tested directly ex vivo in transwell migration
assays. OVA-specific T cells from draining LNs of adoptive
transfer recipients immunized 7 d earlier with OVA peptide
subcutaneously in CFA showed that a strong dose-depen-
dent response to BLC (Fig. 4 A). By contrast, OVA-spe-
cific cells from recipients given the antigen intravenously in
the absence of adjuvant did not respond to BLC (Fig. 4 A).
Kinetic analysis using cells from mice immunized with OVA
peptide in CFA showed the BLC response was detectable by
day 2 and was maximal between days 5 and 10 (Fig. 4 B). In
addition, flow cytometric analysis of transmigrated OVA-
specific cells on day 3 revealed that while most input cells
expressed CXCR5 (Fig. 1 C), there was an enrichment for
cells expressing the highest levels of CXCR5 in the respond-
ing population (Fig. 4 C). These findings provide evidence
for a direct relationship between CXCR5 expression on T
cells and acquisition of BLC responsiveness, although they
do not establish whether the activation state of the cells also
affects their ability to respond. To investigate the BLC re-
sponsiveness of CXCR5-expressing T cells with a resting
phenotype, we took advantage of previous observations that
a subset of memory CD4 T cells expresses CXCR5 (20, 21).
CD4 T cells from aged (
 
$
 
1 yr) mice were characterized as
a source of memory phenotype T cells, and a great majority
of the L-selectin
 
lo
 
 CD4 T cells from these animals were
found to express CXCR5 (Fig. 4 D). In addition to low
L-selectin expression, the majority of CXCR5
 
hi
 
 T cells in
young and old mice expressed high levels of CD44 and re-
duced amounts of CD45RB (data not shown). Most of the
CXCR5
 
hi
 
 cells were also negative for the activation markers
CD69 and CD25, further supporting their designation as
memory cells. Interestingly, though a significant proportion
of memory phenotype T cells in young mice expresses
CXCR5, this proportion was consistently increased in aged
mice (Fig. 4 D). In in vitro chemotaxis assays, the CXCR5hi
memory T cells showed a very similar dose-sensitive BLC
response to the activated OVA-specific T cells character-
ized above (Fig. 4 E). These results establish that both rest-
ing and activated CXCR5hi T cells respond to BLC. Inter-
estingly, although the magnitude of the T cell response to
BLC was lower than that observed for B cells, the T cells
responded maximally to lower concentrations of BLC than
did B cells (Fig. 4 E). This finding is similar to that made
Figure 1. CXCR5 upregulation by in vivo–activated OVA-
specific T cells. (A–E) Histograms depict CXCR5 expression
on non–OVA-specific CD4 cells (KJ1-262) and on gated KJ1-
261B2202CD82 cells from mice that were treated as follows:
(A) unimmunized; (B–E) immunized with OVA peptide sub-
cutaneously in CFA (s.c. KJ1-261) or intravenously in saline
(i.v. KJ1-261); (F) immunized with OVA protein in LPS. In A,
the level of CXCR5 expression on B cells is shown for com-
parison (dashed line). In B–F, the number of days elapsed be-
tween immunization and analysis is displayed in each panel. No
Ag, no antigen injected. The experiment shown in F was per-
formed at a different time from A–E, and has a different level of
background staining. Results are representative of at least three
independent experiments at each time point except panel F,
which is representative of two experiments.
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previously with transfected Jurkat T cells (18), suggesting
that T cells are intrinsically more sensitive than recirculat-
ing B cells to CXCR5 signaling. CD4 T cells express sev-
eralfold less surface CXCR5 than B cells (Fig. 1), demon-
strating that higher surface chemokine receptor expression
does not equate to higher chemokine sensitivity.
CXCR5-expressing T Cells Have Reduced Responsiveness to
the T Zone Chemokines ELC and SLC. T cells have been
shown to respond strongly to ELC and SLC in in vitro
chemotaxis assays (22–24, 27–30). Since these chemokines
are expressed in the T zone and might be able to counteract
the ability of a cell to respond to a chemokine made in fol-
licles, we tested whether CXCR5-expressing T cells were
altered in their responsiveness to ELC and SLC. In striking
contrast to the elevated ELC and SLC responsiveness of
in vitro–activated T cells (28–30), OVA-specific T cells ac-
tivated in vivo by subcutaneous peptide/CFA injection
showed a significant downregulation in responsiveness to
these T zone chemokines (Fig. 5 A). The time course of
this decreased responsiveness to ELC (Fig. 5 B) was similar
to the time course over which the cells became responsive
to BLC (Fig. 4 B). In contrast, OVA-specific T cells from
mice immunized intravenously with peptide in saline main-
tained their ability to respond to ELC throughout the 10-d
time course (Fig. 5 B). Responsiveness to SDF1 was also
decreased in the in vivo–activated T cells (Fig. 5 A), consis-
tent with the recent in vitro finding that anti-CD3 stimula-
tion reduces responsiveness to SDF1 (38). CXCR5-expressing
Figure 2. Follicular homing of
in vivo–activated OVA-specific
T cells and expression pattern of
BLC in secondary follicles. (A–C)
Staining of LN sections to detect
KJ1-261 OVA-specific T cells in
red and CD4 and CD8 in
brown. (D) Staining with peanut
agglutinin (PNA) to detect GCs
in red, and with KJ1-26 to detect
OVA-specific T cells in brown.
Sections are from draining LNs of
mice that received OVA-specific
CD4 T cells and were immu-
nized with OVA peptide subcuta-
neously in CFA 3 (A), 5 (B), or
10 (D) d before isolation, or in-
travenously in saline (C) 3 d be-
fore isolation. (E and F) In situ
hybridization analysis of BLC
expression pattern in LNs con-
taining secondary follicles. BLC
hybridization is seen as dark blue
staining, and sections are costained
in brown for B220 (E) or PNA
(F). The capsular staining in E
was also seen in controls and is
nonspecific. FO, follicle; T, T cell
zone; FM, follicular mantle re-
gion. Original magnifications: A,
C, E, and F, 310; B and D, 35.
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Figure 3. Antigen-specific CD4 T cell expression of CXCR5 during a primary immune response. (A) Representative probability contours for CD44
and CXCR5 expression on Va11Vb3-expressing T cells over the course of a primary response. All profiles are presented as 5% probability contours with
outliers, and are propidium iodide2 CD82B2202CD11b2Va111Vb31. The day after antigen administration is displayed above each panel. The quad-
rants are defined by the horizontal dotted lines, and indicate the limits of CD44 and CXCR5 regulation that were used to calculate the frequencies of
cellular subsets. (B) Frequencies of Va11Vb3-expressing T cells that have upregulated CD44 and are either CXCR52 (left panel) or CXCR51 (right
panel). (C) The total number of antigen-activated Va11Vb3-expressing T cells in the draining LNs as calculated using the frequencies obtained by flow
cytometry and total cell counts estimated when organs were harvested; the left panel represents the CXCR52 subset, the right panel represents the
CXCR51 subset. Each estimation (B and C) is presented as the mean from at least three separate animals 6 SEM.
memory phenotype cells from aged mice showed similarly
low responsiveness to ELC and SLC (Fig. 5 C). Interest-
ingly, in these cells the responsiveness to SDF1 was ele-
vated (Fig. 5 C).
T Cells Can Acquire the Intrinsic Ability to Migrate to Re-
gions of Lymphoid Tissues Proximal to Follicles. The stud-
ies above demonstrate a tight relationship between CD4 T
cell upregulation of CXCR5 expression, acquisition of
BLC responsiveness, and migration into lymphoid follicles
during an immune response. However, they do not estab-
lish whether intrinsic changes in the T cell are sufficient to
direct these cells to follicles or whether additional (extrin-
sic) changes that accompany the adjuvant-induced immune
response are also needed. Although many of the CD4 T
cells in aged mice express CXCR5 (see Fig. 4 C), immuno-
histochemical analysis did not reveal a significantly greater
number of T cells in follicles in aged mice compared with
young mice (data not shown). When CXCR5hi CD4 cells
were transferred from aged to young mice, they were
found to localize within the T zone, with only occasional
cells migrating into follicles (Fig. 6 A). These findings in-
dicate that expression of CXCR5 is not sufficient to direct
all types of T cells into B cell follicles. However, in con-
trast to aged normal mice, aged MRL-lpr mice contain
very large numbers of T cells in a follicular distribution
(39, 40). These CD31 T cells are unusual in lacking CD4
and CD8 and in expressing B220 (39, 40). Flow cytomet-
ric analysis showed that they also express high surface
CXCR5 (Fig. 7 A), and in in vitro chemotaxis assays they
demonstrated a robust response to BLC (Fig. 7 B) and a
reduced response to ELC and SLC (Fig. 7 C). Importantly,
the BLC dose–response curve of the DN T cells was typi-
cal of CXCR51 CD4 T cells (compare Fig. 7 B and Fig.
4, A and D) and not of B cells (see Fig. 4 D). Although the
follicular location of the DN T cells in MRL-lpr mice
suggests these cells have acquired the intrinsic ability to
migrate to follicles, MRL-lpr mice have multiple immu-
nological abnormalities, and it was possible that homing of
DN T cells to follicles was dependent on extrinsic changes
in the lymphoid tissues. To test this directly, DN T cells were
purified from LNs of MRL-lpr mice, labeled with CFSE, and
transferred to normal syngeneic MRL mice. Strikingly, the
transferred T cells migrated to regions proximal to B cell areas
in all secondary lymphoid tissues of the recipient mice (Fig.
6). Differences in the distribution of the cells were noted in
the different tissues. In the spleen, the T cells homed to the
outer rim of the follicles, especially near the marginal zone
bridging channels, and often the cells appeared in contact
with marginal metallophilic macrophages (Fig. 6 B). In LNs
the T cells homed to perifollicular and interfollicular locations
(Fig. 6 C), and in Peyer’s patches the cells were seen to circle
the whole follicular area (Fig. 6 D). These observations dem-
onstrate that T cells can acquire the intrinsic ability to mi-
grate to the boundaries of lymphoid follicles.
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Discussion
The findings above establish that immunization with an-
tigen in adjuvant causes antigen-specific T cells to upregu-
late CXCR5 expression and acquire responsiveness to the
follicular chemokine, BLC, while simultaneously becom-
ing less responsive to the T zone chemokines, ELC and
SLC. We propose that this reprogramming of responsive-
ness to B and T zone chemokines is part of the mechanism
by which antigen-activated T cells home to follicles to help
initiate T-dependent antibody responses.
In the adoptive transfer studies of Jenkins and co-work-
ers, it was observed that antigen needed to be injected in
adjuvant for activated T cells to migrate to follicles (13, 34).
When antigen was injected in the absence of adjuvant, T
cell activation was transient and the activated cells failed to
home to follicles. Our results provide a basis for under-
standing the different trafficking patterns of the activated
cells as they show that CXCR5 upregulation and acquisi-
tion of BLC responsiveness only occurs after injection of
Figure 5. Chemotactic response
profiles of in vivo–activated OVA-
specific T cells and memory pheno-
type CXCR5-expressing T cells.
Results are expressed as percentage
of transmigrated input cells. Bars rep-
resent means of duplicate transwells.
(A) Chemotaxis of KJ1-261CD41
OVA-specific (black bars) and non-
specific CD41 (white bars) cells from
draining LNs of OVA-specific T cell
transfer recipients immunized 7 d
previously with OVA peptide subcu-
taneously in CFA. Chemokine concentrations were: BLC, 2 mg/ml; ELC, 0.2 mg/ml; SLC, 0.2 mg/ml; and SDF1, 0.3 mg/ml. Results were similar at day
5 after immunization and are representative of at least three independent experiments for each chemokine. (B) Response of KJ1-261CD41 OVA-specific
(black bars) and nonspecific CD41 (white bars) cells to 0.2 mg/ml ELC. Cells are from draining LNs of transfer recipients immunized with OVA peptide
subcutaneously in CFA (solid bars) or intravenously in saline (hatched bars). The day after immunization is indicated on the x-axis. Data at day 5 are repre-
sentative of five experiments for subcutaneous immunization in CFA and two experiments for intravenous immunization in saline. (C) Chemotaxis of
CXCR5lo/2 (white bars) and CXCR5hi (black bars) CD41 T cells from the spleen of a 21-mo-old mouse. Chemokine concentrations were: BLC, 2 mg/
ml; ELC, 0.5 mg/ml; SLC, 0.8 mg/ml; and SDF1, 0.3 mg/ml. Results are representative of at least four independent experiments for each chemokine.
CXCR5hi T cells exhibited reduced responsiveness to ELC (0.02–1.5 mg/ml) and SLC (0.08–1.2 mg/ml) at all chemokine concentrations tested.
Figure 4. BLC chemotactic response of
in vivo–activated OVA-specific T cells and
memory phenotype CXCR5-expressing T
cells. Results are expressed as percentage of
transmigrated input cells. Lines represent
means of duplicate transwells. (A) Chemo-
tactic response of KJ1-261CD41 cells from
draining LNs of Balb/c recipients of OVA-
specific CD4 T cells immunized 7 d before
analysis with OVA peptide subcutaneously
in CFA (d) or intravenously in saline (s).
Results were similar at day 5 after immuni-
zation and are representative of five inde-
pendent experiments. (B) Kinetic analysis of
OVA-specific T cell acquisition of BLC re-
sponsiveness. The day after immunization
with OVA peptide subcutaneously in CFA
is indicated in each panel. Differences in
basal migration levels were not reproducible
and reflect assay to assay variability. Results
are representative of at least two indepen-
dent experiments at each time point. (C)
CXCR5 expression on KJ1-261CD41 cells
from day 3 draining LNs showing the total
input population (Input) and the cells that
migrated to BLC (Migrated). (D) CXCR5
and L-selectin (CD62L) expression on CD41
splenocytes from young (left panel) and
21-mo-old (right panel) B6 mice. Numbers
represent the percentage of CD41 and lym-
phocyte size-gated cells in each quadrant.
Similar results, with progressive accumulation of L-selectinlo and CXCR5hi T cells, were obtained for more than 10 animals ,3 or .12 mo of age. (E)
Chemotactic response of CXCR5hi (r) and CXCR5lo/2 (e) CD41 T cells, and of B cells (u) from the spleen of a 21-mo-old mouse. The y-axis on the
left refers to T cells, and on the right to B cells. Results are representative of eight independent experiments.
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antigen in adjuvant. Many studies have indicated that the
effectiveness of adjuvants is through their potent activation
of dendritic cells (DCs [41]), and it is therefore reasonable to
suggest that effective induction of CXCR5 expression on T
cells requires interaction with appropriately activated anti-
gen-presenting DCs within the lymphoid tissue. OX40L is
expressed by a subset of activated DCs (42), and recent stud-
ies by Lane and co-workers provide evidence that stimula-
tion of T cells through OX40 can promote upregulation of
CXCR5 (43) and homing of T cells to follicles (44). Further
studies are needed to define whether additional costimula-
tory molecules can regulate CXCR5 expression on T cells.
In vivo activation by antigen in adjuvant decreases T cell
responsiveness to ELC and SLC at the same time as increas-
ing responsiveness to BLC. This contrasts with findings in
vitro, where PHA- and IL-2–activated T cells responded
more strongly than unactivated cells to SLC and ELC (28–
30) and again indicates that the mode of T cell activation
can strongly influence chemokine responsiveness. Recently,
it has been shown that plt/plt mice, which exhibit defective
homing of T cells to splenic T zones and LNs (45), have a
compound defect that causes a deficiency in SLC expression
and markedly reduced ELC expression (31). This finding
provided strong evidence that SLC and ELC are needed for
T cell homing to lymphoid T cell areas. Therefore, reduced
responsiveness of CXCR5hi T cells to ELC and SLC may
allow the cells to more readily leave the T zone and enter
follicles. Reciprocally, the failure of T cells activated after
intravenous injection of antigen to downregulate their SLC
and ELC response might contribute to their inability to mi-
grate to follicles. Since SLC appears important for cells to
enter LNs via high endothelial venules or lymphatics (22,
31, 46), decreased responsiveness to this chemokine is also
likely to influence the recirculation pattern of the cells.
Figure 6. Transferred MRL-lpr DN T cells, but not memory phenotype CXCR5hi T cells, home towards B cell follicles in secondary lymphoid or-
gans of unimmunized nonautoimmune mice. Spleen (A and B), LN (C), and Peyer’s patch (PP; D) sections from syngeneic recipients of CFSE-labeled
(A) CD41 CXCR51-enriched splenocytes from 12–15-mo-old mice or (B–D) purified DN T cells from 8-mo-old MRL-lpr mice. Recipient tissues
were isolated 1 d after cell transfer. CFSE-labeled cells are green. T cells are stained in red using mAbs to CD3e and Thy1.2 (A and B), CD8 (C), or CD4
(D). MOMA-11 marginal zone metallophilic macrophages are stained blue. A is representative of five and B–D of three mice. F, follicle; T, T cell zone;
MZ, marginal zone. Original magnification: 310.
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Our studies provide strong evidence that altered respon-
siveness to constitutively expressed chemokines is part of
the mechanism by which antigen-activated CD4 T cells
migrate towards and into B cell follicles. This conclusion is
also supported by the transfer experiments showing that DN
T cells from MRL-lpr mice are intrinsically capable of mi-
grating to areas proximal to follicles (Fig. 6). However, the
failure of CXCR5hi CD4 T cells to migrate to follicles after
adoptive transfer suggests that additional factors might nor-
mally help guide antigen-activated CD4 T cells. The migra-
tion of only a subset of OVA-activated T cells to follicles also
suggests that CXCR5hi cells may be heterogeneous in their
responsiveness to these factors. Several studies have shown
that B cell receptor–stimulated B cells upregulate expres-
sion of chemokines, including MIP-1a, MIP-1b (47, 48),
and macrophage-derived chemokine (MDC [49]), that can
attract subsets of activated T cells (50–53). Since antigen-
activated B cells move to the boundary of B and T zones
(3), it is likely that chemokines produced by activated B cells
work together with constitutively expressed chemokines to
bring antigen-activated T cells to the outer T zone. Whether
further cues are needed to direct cells from the outer T
zone into follicles remains unclear, although the failure of
MRL-lpr DN T cells to migrate to the inner regions of fol-
licles suggests this is the case. Possibilities include changes in
the responsiveness of the T cells to other unknown chemo-
kines, and changes in the relative adhesiveness of the cells
for features of the B or T cell compartments. Several exam-
ples of cell sorting occurring as a result of differential adhe-
siveness of cells have been reported (54–56).
A major role of T cells inside follicles is to support the GC
response (1, 2). 9 d after immunization with PCC in adju-
vant, a large majority of the PCC-responsive Va11Vb3-
expressing T cells express CXCR5 (Fig. 3), and at this time
point, z75% of the cells are localized within GCs (17).
Therefore, at least a subset of PCC-responsive CXCR5hi
T cells acquires the ability to enter GCs. Similarly, in the
DO11.10 adoptive transfer system, 10 d after immunization
with OVA peptide in CFA, the majority of KJ1-261 T cells
were CXCR5hi, and many cells were found in follicular
mantle zones and GCs (Fig. 2 D). The strong expression of
BLC in primary follicles (18) and in follicular mantle zones
of secondary follicles (Fig. 2, E and F) is consistent with
BLC playing a role in attracting T cells to these sites. The
presence of only small numbers of BLC-expressing cells
within GCs, predominantly in the region distal to the T
zone (most likely corresponding to the GC light zone [1])
suggests that while BLC/CXCR5 might have a role in
helping position cells within GCs, additional cues are likely
to be needed. These findings also establish that there is sub-
stantial heterogeneity among follicular stromal cells in terms
of BLC expression levels, with GC follicular DCs express-
ing relatively little of this chemokine. Perhaps by being con-
centrated predominantly outside the T zone–distal pole of
the GC, BLC helps polarize the GC light and dark zone
compartments. The notion that cues other than BLC play
important roles in GC organization is supported by the
finding that GCs are able to form in CXCR5-deficient
mice (21). Furthermore, although spleens of CXCR5-defi-
cient mice lack polarized follicles and contain aberrantly
located GCs, the follicular disruption in LNs appeared to
be minimal (21). Although this suggests that the role of
CXCR5/BLC in B and T cell homing to LN follicles is re-
dundant to other chemokine/receptor systems, studies in
mice lacking lymphotoxin or TNF have shown that effects
on follicular organization in LNs are more difficult to detect
than in spleen or Peyer’s patches (57, 58), yet these effects
can still be substantial (59, 60). As we have shown here,
BLC is expressed in LN follicles, and CXCR5 is strongly
upregulated on activated T cells in LNs. Future studies of
BLC-deficient mice should help further dissect the contri-
bution of BLC and CXCR5 to follicular organization and
GC formation in LNs.
T cell homing to follicles may be important not only for
providing help to B cells, but also for providing activated T
cells with growth and survival signals. This possibility is
suggested by the finding that antigen injected in the ab-
sence of adjuvant fails to promote T cell migration to follicles,
and also fails to promote survival of activated or memory T
cells (13, 34). The selective accumulation of the CXCR5-
expressing subset of CD4 T cells in aged mice (Fig. 4 C)
and in HIV-infected humans during disease progression
(61) is consistent with the notion that trafficking through B
cell areas plays a role in long-term survival of memory T
cells. This possibility is also supported by the finding of a de-
fect in CD4 T cell memory in B cell–deficient mice (62).
Although we did not observe trafficking of CXCR5hi mem-
ory T cells to follicles in short-term transfer experiments,
Figure 7. CXCR5 expression and chemo-
tactic response profile of DN T cells from
MRL-lpr mice. (A) CXCR5 expression on
DN (Thy11B2201) and conventional
(Thy11B2202) T cells. DN T cells stained
with the secondary antibody alone (no 18
Ab) are shown as a control. (B and C)
Chemotaxis of a 3:1 mixture of MRL-lpr
and B6 splenocytes in response to (B) BLC
and (C) a panel of lymphoid chemokines.
Results are expressed as percentage of input
cells transmigrated for DN T cells (d) and
conventional T cells (s). Chemokine con-
centrations in C: BLC, ELC, and SLC, 1 mg/ml; SDF1, 0.3 mg/ml. MRL-lpr mice were old 5 mo at the time of analysis. Lines (B) and bars (C) represent
means of duplicate transwells. Results in A are representative of three, and in B and C of two independent experiments.
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studies in rats have suggested that memory T cells migrate
through follicles at greater frequency than naive T cells (63).
In summary, our findings suggest a model for how helper
T cells home to follicles. After engagement of peptide/MHC
complexes on appropriately activated T zone DCs, CD4 T
cells upregulate CXCR5, acquire responsiveness to the folli-
cular chemokine BLC, and simultaneously downregulate
responsiveness to the T zone chemokines ELC and SLC.
Together with additional presently undefined changes, this
reprogrammed chemokine responsiveness helps propel T
cells toward B cell areas. Further cues, such as those emanat-
ing from activated B cells and from GC cells, can then act
upon these T cells to more precisely control their positioning
and facilitate their ability to act as B cell helpers.
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